Article · 12 Jun 2026
EditorialPublished 2011
Nontraditional Study Designs for Proving Bioequivalence
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
From past many years, concerns have been expressed regarding meeting the standard bioequivalence (BE) criteria for highly variable drugs. This has been point of discussion in many conferences and meetings. But to date there is no as such regulatory definition for these drugs or drug products. To pass conventional goal posts for these drugs, the number of subjects required for a study can be much higher than normally needed for a typical BE study. The resources required and the ethical concerns of exposing large number of healthy volunteers to a test drug further poses challenge to the suitability of conventional BE criteria (with an 80-125% acceptance range) for highly variable drugs. Examples exist where a highly variable reference product failed to demonstrate BE when compared to itself in a bioequivalent study using the standard design/sample size.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 5 May 2025
Clinical Trial Design for Narrow Therapeutic Index Drugs in Bioequivalence Studies
Article · 4 Mar 2025
Innovations in Clinical Trial Design to Improve Bioequivalence Assessments for Complex Generics
Conference abstract · 28 Feb 2019
Design of bioavailability and bioequivalence studies through PK-Stat approach
Review article · 16 May 2016
A Review Of The Development Of Biostatistical Design And Analysis Techniques For Assessing In Vivo Bioequivalence : Part One
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sneha Latha”
